APA (7th ed.) Citation

A, T., PS, W., P, F., K, S., N, J., V, J., . . . J, R. (2026). Omission of Axillary Lymph Node Dissection in Patients with pT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis. Annals of surgical oncology, 33(2), 1189. https://doi.org/10.1245/s10434-025-18546-5

Chicago Style (17th ed.) Citation

A, Tang, Wu PS, Farmah P, Schulz-Costello K, Johnson N, Jones V, Bazan J, and Rand J. "Omission of Axillary Lymph Node Dissection in Patients with PT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis." Annals of Surgical Oncology 33, no. 2 (2026): 1189. https://doi.org/10.1245/s10434-025-18546-5.

MLA (9th ed.) Citation

A, Tang, et al. "Omission of Axillary Lymph Node Dissection in Patients with PT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis." Annals of Surgical Oncology, vol. 33, no. 2, 2026, p. 1189, https://doi.org/10.1245/s10434-025-18546-5.